The blog
Clinical trial results, TGA regulatory progress and research updates on retatrutide and the wider peptide space — explained for Australians.
12 September 2026 · selank · peptides · research · australia · regulation
Selank is marketed for anxiety, yet much of its research is immunological. What the Selank research actually shows - and its legal status in Australia.
Read more →9 September 2026 · selank · peptides · anxiety · tga · research
What is Selank? The 2015 Russian trial tested it alongside a benzodiazepine, not instead of one. The real evidence, plus Selank's legal status in Australia.
Read more →Stay informed
Retatrutide is not yet available to the public. But when it is, you will want to be first to know. Sign up to receive:
Get the free guide + updates
Enter your details once on our free access guide page — instant download, plus we'll email you the moment there's real news.